GeneFerm Biotechnology , Ltd. Profit Margin

GeneFerm Biotechnology , Ltd.'s profit margin stands at 2.57% as of June 2026. That compares with -0.13% in the prior-year period — up 2047.4% year over year. That is below the sector sector average of 13.16%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

GeneFerm Biotechnology , Ltd. reported 2.57% in profit margin versus -0.13% a year earlier — a 2047.4% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

GeneFerm Biotechnology , Ltd. sits lower the its sector benchmark (13.16%) with a profit margin of 2.57%. That is roughly 80.5% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 2.57% for GeneFerm Biotechnology , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how GeneFerm Biotechnology , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 1796.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.